245 related articles for article (PubMed ID: 20602789)
1. Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions.
Zagouri F; Sergentanis TN; Nonni A; Papadimitriou CA; Michalopoulos NV; Domeyer P; Theodoropoulos G; Lazaris A; Patsouris E; Zogafos E; Pazaiti A; Zografos GC
BMC Cancer; 2010 Jul; 10():353. PubMed ID: 20602789
[TBL] [Abstract][Full Text] [Related]
2. Decreased Hsp90 expression in infiltrative lobular carcinoma: an immunohistochemical study.
Zagouri F; Sergentanis T; Nonni A; Papadimitriou C; Pazaiti A; Michalopoulos NV; Safioleas P; Lazaris A; Theodoropoulos G; Patsouris E; Zografos G
BMC Cancer; 2010 Aug; 10():409. PubMed ID: 20691061
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein90 in lobular neoplasia of the breast.
Zagouri F; Nonni A; Sergentanis TN; Papadimitriou CA; Michalopoulos NV; Lazaris AC; Patsouris E; Zografos GC
BMC Cancer; 2008 Oct; 8():312. PubMed ID: 18957107
[TBL] [Abstract][Full Text] [Related]
4. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 expression in ductal carcinoma in situ, atypical ductal hyperplasia and usual ductal hyperplasia: an immunohistochemical study.
Umekita Y; Yoshida H
Pathol Int; 2000 Jul; 50(7):527-30. PubMed ID: 10886733
[TBL] [Abstract][Full Text] [Related]
6. COX-2, p16 and Ki67 expression in DCIS, microinvasive and early invasive breast carcinoma with extensive intraductal component.
Bartova M; Ondrias F; Muy-Kheng T; Kastner M; Singer Ch; Pohlodek K
Bratisl Lek Listy; 2014; 115(7):445-51. PubMed ID: 25077370
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of HSP90 in the continuum of breast ductal and lobular lesions.
Zagouri F; Sergentanis TN; Provatopoulou X; Kalogera E; Chrysikos D; Lymperi M; Papadimitriou CA; Zografos E; Bletsa G; Kalles VS; Zografos GC; Gounaris A
In Vivo; 2011; 25(4):669-72. PubMed ID: 21709012
[TBL] [Abstract][Full Text] [Related]
8. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia.
Gillett CE; Lee AH; Millis RR; Barnes DM
J Pathol; 1998 Apr; 184(4):396-400. PubMed ID: 9664905
[TBL] [Abstract][Full Text] [Related]
11. Different proliferative patterns characterize different preinvasive breast lesions.
Viacava P; Naccarato AG; Bevilacqua G
J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
[TBL] [Abstract][Full Text] [Related]
12. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
Chen CL; Chu JS; Su WC; Huang SC; Lee WY
Virchows Arch; 2010 Jul; 457(1):53-61. PubMed ID: 20526721
[TBL] [Abstract][Full Text] [Related]
14. [Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].
Ma L; Zhang XH; Xing LX; Li YH; Wang XL; Wang YJ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):279-83. PubMed ID: 18788632
[TBL] [Abstract][Full Text] [Related]
15. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
16. [Expression of Fascin-1 protein in breast cancer and its clinicopathologic correlation].
Wang C; Huang B; Wu Z; Sun X; Zeng Y; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):451-4. PubMed ID: 25327793
[TBL] [Abstract][Full Text] [Related]
17. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis.
Simooka H; Oyama T; Sano T; Horiguchi J; Nakajima T
Pathol Int; 2004 Aug; 54(8):595-602. PubMed ID: 15260850
[TBL] [Abstract][Full Text] [Related]
19. Promoter CpG island hypermethylation during breast cancer progression.
Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
[TBL] [Abstract][Full Text] [Related]
20. Protein expression of c-erbB-2 and p53 in normal ducts, ductal carcinoma in situ and invasive carcinoma of the same breast.
Menezes MV; Cestari AL; Almeida O; Alvarenga M; Pinto GA; Gurgel MS; Souza GA; Zeferino LC
Sao Paulo Med J; 2006 May; 124(3):121-4. PubMed ID: 17119686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
